Milk Thistle and Silymarin: What the Research Actually Shows

Milk thistle has been used for liver complaints for over 2,000 years. This article examines the active compound silymarin, how it works, and what clinical evidence exists.

Milk thistle (Silybum marianum) is a flowering herb native to the Mediterranean region, now found throughout the world. Its seeds have been used medicinally for over 2,000 years, principally for conditions involving the liver and gallbladder. Milk thistle is one of the most extensively researched herbal supplements in modern pharmacognosy.

What silymarin is

The active component in milk thistle seed extract is a complex of flavonolignans collectively known as silymarin. Silymarin is not a single compound — it is a mixture, with the most abundant and best-studied constituent being silybin (also spelled silibinin), which makes up 50–70% of silymarin. Other components include silydianin and silychristin. Commercial extracts are typically standardised to 70–80% silymarin content.

Mechanisms of action

Silymarin has been studied for several biological mechanisms:

  • Antioxidant activity: Silymarin is a potent scavenger of free radicals and increases cellular glutathione levels — the liver's primary endogenous antioxidant.
  • Membrane stabilisation: It alters the outer membrane of liver cells in a way that inhibits the uptake of certain toxins, including Amanita phalloides (death cap mushroom) toxins — which is the basis for its emergency medical use in mushroom poisoning.
  • Anti-fibrotic effects: In vitro and animal studies show silymarin inhibits hepatic stellate cell activation, the process that drives liver fibrosis (scarring). Clinical translation of this mechanism is still being established.
  • Anti-inflammatory activity: Silymarin inhibits NF-κB and reduces production of pro-inflammatory cytokines in liver tissue.

Clinical evidence

Clinical trials of milk thistle have been conducted primarily in people with alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and viral hepatitis. A 2005 Cochrane review concluded that while silymarin appeared to reduce liver-related mortality in cirrhosis patients, the evidence was insufficient to confirm efficacy for all clinical endpoints due to methodological limitations in the available studies. More recent meta-analyses in NAFLD patients have found statistically significant reductions in liver enzymes (ALT and AST) — biomarkers of liver inflammation — with silymarin supplementation.

It is worth noting that silymarin's bioavailability is limited by its poor water solubility. Newer formulations using phospholipid complexes (such as Siliphos/Silybin-Phosphatidylcholine) show improved absorption and higher plasma concentrations.

Traditional use in the Mediterranean

Historically, milk thistle was used across the Mediterranean — including the Levant region — as a food and medicine. Young shoots were eaten as a vegetable, and the seeds were used to make herbal preparations for liver and gallbladder complaints. This long history of use predates modern clinical evidence by millennia.

Milk thistle in Lebanon

Supplements & More carries standardised milk thistle (silymarin) supplements from US brands, available with cash on delivery across Lebanon.


حليب الشوك والسيليمارين: ما تكشفه الأبحاث فعلاً

استُخدم حليب الشوك في شكاوى الكبد لأكثر من 2000 عام. تفحص هذه المقالة المركَّب النشط السيليمارين وكيف يعمل وما الأدلة السريرية الموجودة.

حليب الشوك (Silybum marianum) عشبة مزهرة مشهورة في حوض البحر الأبيض المتوسط، استُخدمت بذورها دوائياً لأكثر من 2000 عام، وبخاصة لأحوال الكبد والمرارة.

ما هو السيليمارين

المكوّن النشط في مستخلص بذور حليب الشوك هو مجموعة من الفلافونوليغنان المعروفة مجتمعةً بـالسيليمارين. ليس مركَّباً واحداً بل خليطاً، أكثر مكوناته وفرةً ودراسةً هو السيليبين، الذي يشكّل 50-70% من السيليمارين. تُقنَّن المستخلصات التجارية عادةً إلى محتوى 70-80% سيليمارين.

آليات العمل

دُرس السيليمارين لعدة آليات: النشاط المضاد للأكسدة ورفع مستويات الغلوتاثيون الخلوي، وتثبيط استيعاب بعض السموم في خلايا الكبد، والخصائص المضادة للتليف ومضادة الالتهاب.

الأدلة السريرية

أُجريت التجارب السريرية لحليب الشوك بشكل رئيسي لدى مرضى الكبد الكحولي والكبد الدهني غير الكحولي والتهاب الكبد الفيروسي. تُظهر التحليلات التلوية انخفاضاً ذا دلالة إحصائية في إنزيمات الكبد (ALT وAST) مع تناول السيليمارين.

المنتج المتوفر

يتوفر في Supplements & More مكملات حليب الشوك الموحَّدة من علامات أمريكية، مع الدفع عند الاستلام في لبنان.